Cover Image
市場調查報告書

隱孢子蟲症:全球臨床實驗檢討

Cryptosporidiosis Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 196106
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
隱孢子蟲症:全球臨床實驗檢討 Cryptosporidiosis Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月19日 內容資訊: 英文 35 Pages
簡介

本報告提供隱孢子蟲症的治療藥相關的臨床實驗資料,提供您臨床實驗數及受驗者人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥的資訊等彙整資料。

簡介

各地區的臨床實驗趨勢

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家

G7各國的臨床試驗

G7各國的臨床試驗:各進展狀況

Phase別的臨床試驗

  • 進行中的臨床實驗:Phase別

臨床試驗:各進展狀況

臨床試驗:評估項目別

未完成的臨床實驗

每段時期的實驗人數

臨床試驗:贊助商各類型

有力的贊助商

  • 隱孢子蟲症臨床實驗參加中的主要企業

潛力治療藥物比較

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Romark Laboratories, LC
    • Sanofi
    • Pfizer Inc
    • Johnson & Johnson
    • Univax Biologics Inc
    • Stolle Milk Biologics, Inc
    • Rhone-Poulenc Rorer (SA) (Pty) Ltd
    • AbbVie Inc 32
  • 主要大學/實驗室/醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • 名古屋大學大學院醫學系研究科·醫學系醫學專業
    • Cornell University
    • Tufts University

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4350CTIDB

GlobalData's clinical trial report, "Cryptosporidiosis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptosporidiosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptosporidiosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in North America 9
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 10
  • Clinical Trials by G7 Countries: Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials 11
  • Clinical Trials by Phase in G7 Countries 13
  • Clinical Trials in G7 Countries by Trial Status 14
  • Clinical Trials by Phase 15
  • Clinical Trials by Trial Status 16
  • Clinical Trials by End Point Status 17
  • Clinical Trials by Sponsor Type 18
  • Prominent Sponsors 19
  • Top Companies Participating in Cryptosporidiosis Therapeutics Clinical Trials 21
  • Clinical Trial Profile Snapshots 23

Appendix 33

  • Abbreviations 33
  • Definitions 33
  • Research Methodology 34
  • Secondary Research 34
  • About GlobalData 35
  • Contact Us 35
  • Source 35

List of Tables

List of Tables

  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 8
  • Cryptosporidiosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 9
  • Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 10
  • Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 12
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase, 2017* 15
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 16
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 17
  • Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 18
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 20
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 22

List of Figures

List of Figures

  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 8
  • Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 10
  • Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 11
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 13
  • Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 14
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 15
  • Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 16
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 17
  • Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 18
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 19
  • Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 21
  • GlobalData Methodology 34
Back to Top